CIR Expert Panel Seeks Proper Balance In Respiratory Exposure Doc, Says Particle Size Isn’t All-Important
Executive Summary
The Cosmetic Ingredient Review’s efforts to finalize an Aerosols resource document show the program’s public interchange at work. At its Dec. 3-4 meeting, the CIR Expert Panel was divided on whether the document properly characterizes the importance of particle size in assessing the inhalation risks of ingredients in aerosol cosmetics, a point raised by NGO Women’s Voices for the Earth.
You may also be interested in...
CIR’s Silica/Silicates Review Could Be First Test Of Panel’s Revised Inhalation Assessment Approach
The Cosmetic Ingredient Review Expert Panel has been grappling with the question of just how vital particle-size data is to assessing the potential inhalation risks of ingredients used in cosmetic sprays and powders. Its pending review of silica/silicate ingredients could provide a look at the panel’s evolving approach in action, with particle size data for all ingredients requested from industry ASAP.
CIR Panel: Epidemiology Evidence Still Lacking Regarding Possible Hair Dye-Cancer Links
Potential connections between hair-dye use and cancer incidence have been just hazily sketched in epidemiological studies to date, signaling a need for more targeted, better-designed investigations, CIR’s Expert Panel says. The group finalized a related resource document at its December meeting in Washington after multiple rounds of revisions and outside expert input.
FDA Researchers Analyze OTC Spray, Powder Products, Finding Possible Respiratory Risks
Of 32 OTC drug products intended for topical uses but marketed in spray or powder forms – mostly sunscreens and antiperspirants – the powder formulas overall contained larger percentages of particles in the sub-5 µm range capable of penetrating deep into the lungs. The researchers say the study does not reflect agency views or policies but could be useful to FDA in its public health mission.